| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |